PRJNA767497
T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy for Stage I Non-Small-Cell Lung Cancer
Radiotherapy is known to influence immune function, including T cell receptor (TCR) repertoire. We evaluated the TCR repertoire before and after stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer (NSCLC) and explored correlations between TCR indexes and distant failure after SBRT.